Biosimilars (e.g., trastuzumab, rituximab)
Oncology, Autoimmune diseases
ApprovedCommercial
Key Facts
About Aspen Pharmacare
Aspen Pharmacare is a leading South African multinational pharmaceutical company with a vast global footprint, improving patient health in over 115 countries through high-quality, affordable medicines. The company operates through two key business segments: Manufacturing and Commercial Pharmaceuticals, with a diverse portfolio covering sterile injectables, oral solid doses, liquids, semi-solids, biologicals, and active pharmaceutical ingredients (APIs). With a strong leadership team and a commitment to integrity and innovation, Aspen holds manufacturing approvals from stringent global regulatory agencies like the US FDA, positioning it as a significant player in the global generics and specialty pharma market.
View full company profileTherapeutic Areas
Other Oncology, Autoimmune diseases Drugs
| Drug | Company | Phase |
|---|---|---|
| Biosimilars Pipeline | Laurus Labs | Development |
| Novel Monoclonal Antibodies | Changchun High-Tech Industry | Pre-clinical |
| Biosimilar (Rituximab) | Ipca Laboratories | Development |
| Biosimilar Candidates | China Resources Pharmaceutical Group | Phase 3 |
| Biosimilar Pipeline (Confidential) | Gland Pharma | Development |